WHO adds new drugs to its essential medicines’ list

Prices of cancer, diabetes, antimicrobials, antifungal drugs and tobacco cessation medicines may decline in India with the World Health Organization (WHO) including these drugs in the new edition of its Model Lists of Essential Medicines and Essential Medicines for Children published on Friday

Neetu Chandra Sharma
Published1 Oct 2021, 11:46 PM IST
The updated list includes cancer and antimicrobial drugs.reuters
The updated list includes cancer and antimicrobial drugs.reuters

Prices of cancer, diabetes, antimicrobials, antifungal drugs and tobacco cessation medicines may decline in India with the World Health Organization (WHO) including these drugs in the new edition of its Model Lists of Essential Medicines and Essential Medicines for Children published on Friday.

Antimicrobial drugs and those for fungal diseases such as mucormycosis surged during the pandemic, especially in the second wave. WHO’s updated essential medicines’ list includes 20 new medicines for adults and 17 for children and specifies new uses for 28 already-listed medicines.

WHO said high prices for both new, patented medicines and older medicines such as insulin continue to keep some essential medicines out of reach for many patients.

WHO’s model lists of essential medicines refer to those medicines that satisfy the priority healthcare needs of most of the population.

WHO noted that diabetes is spreading faster in low- and middle-income countries.

“Too many people who need insulin encounter financial hardship in accessing it or go without it and lose their lives. Including insulin analogues (an altered form of insulin) in the essential medicines’ list, coupled with efforts to ensure affordable access to all insulin products and expand use of biosimilars, is a vital step towards ensuring everyone who needs this life-saving product can access it,” said Dr Tedros Adhanom Ghebreyesus, director-general, WHO.

As per International Diabetes Federation, 463 million people have diabetes globally with 88 million people in South-east Asia. Of this, 77 million are in India with 8.9% prevalence of diabetes in the population.

WHO noted that insulin production is concentrated in a small number of manufacturing facilities, and three firms control most of the global market. The lack of competition has led to high drug prices that are prohibitive for many people and health systems, it said.

“Inclusion in the list means that biosimilar insulin analogues can be eligible for WHO’s prequalification programme; WHO prequalification can result in more quality-assured biosimilars entering the international market, creating competition to bring prices down and giving countries a greater choice of products,” said WHO.

Public health experts in India appreciated the move.

“Overall, this step of the WHO is welcome, specifically in relation to availability of life and heart saving SGLT2 inhibitor drugs at primary level. However, decision of provision of insulin analogues at primary levels is intriguing because these cost 2-5 times more than regular insulin and add nothing to efficacy in lowering blood sugar, apart from lower tendency to cause hypoglycemia. At primary level (and at all levels), low-cost regular insulins work as effectively as any highly publicized expensive insulins,” said Dr Anoop Misra, chairman at Fortis-C-DOC and president of Diabetes Foundation (India).

In the case of cancer treatment, four new drugs were added to the model lists—Enzalutamide as an alternative to abiraterone for prostate cancer; Everolimus for subependymal giant cell astrocytoma (SEGA), a type of brain tumour in children; Ibrutinib, a targeted medicine for chronic lymphocytic leukaemia; and Rasburicase for tumour lysis syndrome, a serious complication of some cancer treatments.

Catch all the Business News , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.

MoreLess
First Published:1 Oct 2021, 11:46 PM IST
Business NewsNewsWorldWHO adds new drugs to its essential medicines’ list

Get Instant Loan up to ₹10 Lakh!

  • Employment Type

    Most Active Stocks

    Indian Oil Corporation share price

    138.90
    03:59 PM | 4 NOV 2024
    -6.1 (-4.21%)

    Tata Steel share price

    146.95
    03:56 PM | 4 NOV 2024
    -2.75 (-1.84%)

    Reliance Industries share price

    1,302.00
    03:59 PM | 4 NOV 2024
    -37.1 (-2.77%)

    Tata Motors share price

    824.10
    03:59 PM | 4 NOV 2024
    -19.5 (-2.31%)
    More Active Stocks

    Market Snapshot

    • Top Gainers
    • Top Losers
    • 52 Week High

    City Union Bank share price

    178.10
    03:29 PM | 4 NOV 2024
    0.25 (0.14%)

    Federal Bank share price

    204.15
    03:59 PM | 4 NOV 2024
    -0.1 (-0.05%)

    Jubilant Pharmova share price

    1,252.35
    03:40 PM | 4 NOV 2024
    -11.65 (-0.92%)

    UTI Asset Management Company share price

    1,326.85
    03:29 PM | 4 NOV 2024
    -33.4 (-2.46%)
    More from 52 Week High

    Poly Medicure share price

    2,876.70
    03:43 PM | 4 NOV 2024
    -286 (-9.04%)

    Vodafone Idea share price

    7.89
    03:59 PM | 4 NOV 2024
    -0.56 (-6.63%)

    Chennai Petroleum Corporation share price

    614.70
    03:45 PM | 4 NOV 2024
    -40.85 (-6.23%)

    Angel Broking share price

    2,886.35
    03:59 PM | 4 NOV 2024
    -184.55 (-6.01%)
    More from Top Losers

    Fine Organic Industries share price

    5,123.00
    03:29 PM | 4 NOV 2024
    280.9 (5.8%)

    Firstsource Solutions share price

    358.85
    03:50 PM | 4 NOV 2024
    18.55 (5.45%)

    Rainbow Childrens Medicare share price

    1,630.70
    03:59 PM | 4 NOV 2024
    81.1 (5.23%)

    Gillette India share price

    10,323.35
    03:29 PM | 4 NOV 2024
    361.55 (3.63%)
    More from Top Gainers

    Recommended For You

      More Recommendations

      Gold Prices

      • 24K
      • 22K
      Bangalore
      80,415.000.00
      Chennai
      80,421.000.00
      Delhi
      80,573.000.00
      Kolkata
      80,425.000.00

      Fuel Price

      • Petrol
      • Diesel
      Bangalore
      102.92/L0.00
      Chennai
      101.03/L0.23
      Kolkata
      104.95/L0.00
      New Delhi
      94.77/L0.00

      Popular in News

        HomeMarketsPremiumInstant LoanMint Shorts